Probiotics ameliorate pioglitazone-associated bone loss in diabetic rats
Pioglitazone, as a PPAR gamma agonist, is used for the management of type 2 diabetes mellitus. Nevertheless, evidence showed that the therapeutic modulation of PPAR gamma activity using pioglitazone might be l...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Ahmad Gholami, Mohammad Hossein Dabbaghmanesh, Younes Ghasemi, Pedram Talezadeh, Farhad Koohpeyma and Nima Montazeri-Najafabady Tags: Research Source Type: research
More News: Actos | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Metabolic Syndrome | Probiotics